AngioDynamics (ANGO) News Today → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free ANGO Stock Alerts $5.78 -0.09 (-1.53%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHead to Head Review: Allurion Technologies (NYSE:ALUR) and AngioDynamics (NASDAQ:ANGO)americanbankingnews.com - April 21 at 1:44 AMAngioDynamics, Inc. (ANGO) Interactive Stock Chart - Yahoo Financefinance.yahoo.com - April 17 at 8:36 PMAngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Down 8.5% in Marchamericanbankingnews.com - April 17 at 3:44 AMAngioDynamics, Inc. (NASDAQ:ANGO) Sees Large Decline in Short Interestmarketbeat.com - April 15 at 11:13 PMInsider Spends US$67k Buying More Shares In AngioDynamicsfinance.yahoo.com - April 10 at 9:25 AMA Leaner AngioDynamics Is A High-Risk Execution-Driven Storyseekingalpha.com - April 9 at 5:16 PMJames C. Clemmer Acquires 10,000 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) Stockinsidertrades.com - April 9 at 4:46 AMInsider Buying: AngioDynamics, Inc. (NASDAQ:ANGO) CEO Purchases 10,000 Shares of Stockmarketbeat.com - April 8 at 6:41 PMAngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call Transcriptfinance.yahoo.com - April 8 at 10:12 AMAngioDynamics Third Quarter 2024 Earnings: Misses Expectationsfinance.yahoo.com - April 6 at 10:55 AMAngioDynamics (ANGO) Q3 2024 Earnings Call Transcriptseekingalpha.com - April 6 at 12:12 AMBuy Rating Affirmed for AngioDynamics Amid Strong Sales and Strategic Growth Opportunitiesmarkets.businessinsider.com - April 6 at 12:12 AMBuy Rating Reaffirmed for AngioDynamics Amidst Strategic Growth and Med-Tech Sector Potentialmarkets.businessinsider.com - April 6 at 12:12 AMAngioDynamics upgraded at Oppenheimer on pipeline progressmsn.com - April 5 at 2:12 PMMedical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock Soarsfinance.yahoo.com - April 4 at 6:09 PMAngioDynamics Shares Rise 10% After FDA Clears AlphaVac F18 Systemmarketwatch.com - April 4 at 1:09 PMANGO Stock Earnings: AngioDynamics Misses EPS, Misses Revenue for Q3 2024markets.businessinsider.com - April 4 at 1:09 PMAngioDynamics (NASDAQ:ANGO) Releases FY 2024 Earnings Guidancemarketbeat.com - April 4 at 8:41 AMAngioDynamics Gets FDA Clearance For Pulmonary Embolism Treatmentmarketwatch.com - April 4 at 8:08 AMAngioDynamics Cut Fiscal-Year Revenue Outlook, Reflecting Divestmentsmarketwatch.com - April 4 at 8:08 AMAngioDynamics: Fiscal Q3 Earnings Snapshotsfgate.com - April 4 at 8:08 AMAngioDynamics: FDA Clears AlphaVac F1885 System In Treatment Of Pulmonary Embolismmarkets.businessinsider.com - April 4 at 8:08 AMAngioDynamics Q3 Loss Sharply Widens; Slashes FY24 Outlookmarkets.businessinsider.com - April 4 at 8:08 AMAngioDynamics gets FDA clearance for pulmonary embolism treatment devicemsn.com - April 4 at 8:08 AMAngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiturebusinesswire.com - April 4 at 7:00 AMAngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PEbusinesswire.com - April 4 at 6:45 AMAngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreementmsn.com - April 2 at 10:57 AMAngioDynamics Settles All Patent Litigation With C.R. Bardmarkets.businessinsider.com - April 2 at 1:09 AMAngioDynamics Settles Multi-Year Patent Dispute with Becton Dickinson & Comarketwatch.com - April 1 at 8:08 PMAngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.businesswire.com - April 1 at 5:26 PMAngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024businesswire.com - March 19 at 4:01 PMQ3 2024 EPS Estimates for AngioDynamics, Inc. Reduced by Zacks Research (NASDAQ:ANGO)marketbeat.com - March 18 at 2:02 AMShort Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Rises By 8.5%marketbeat.com - March 18 at 12:48 AMQ3 2026 EPS Estimates for AngioDynamics, Inc. Lowered by Zacks Research (NASDAQ:ANGO)marketbeat.com - March 15 at 7:48 AMJacobs Levy Equity Management Inc. Grows Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)marketbeat.com - March 14 at 5:13 AMAngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conferencebusinesswire.com - March 6 at 4:01 PMTrexquant Investment LP Makes New Investment in AngioDynamics, Inc. (NASDAQ:ANGO)marketbeat.com - March 5 at 7:53 AMHidden Gems: 7 Oversold Stocks Ready for a Major Reboundinvestorplace.com - March 4 at 6:42 PMAngioDynamics (ANGO) Gains But Lags Market: What You Should Knowfinance.yahoo.com - March 1 at 11:44 PMAcadian Asset Management LLC Invests $2.63 Million in AngioDynamics, Inc. (NASDAQ:ANGO)marketbeat.com - February 26 at 6:20 AMAngioDynamics sells PICC and Midline portfolios for $45 millioninvesting.com - February 18 at 12:51 AMELV Feb 2024 410.000 putfinance.yahoo.com - February 17 at 12:08 AMAngioDynamics divests PICC, Midline product portfoliomsn.com - February 16 at 7:07 PMAngioDynamics (ANGO) Divests Its PICC & Midline Businessesfinance.yahoo.com - February 16 at 2:06 PMPrincipal Financial Group Inc. Decreases Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)marketbeat.com - February 16 at 4:16 AMAngioDynamics Sells PICC, Midline Products for Up to $45 Millionmarketwatch.com - February 15 at 6:03 PMAngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Millionfinance.yahoo.com - February 15 at 6:03 PMAngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Millionbusinesswire.com - February 15 at 4:05 PMAngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Up 26.0% in Januarymarketbeat.com - February 13 at 9:47 AMAngioDynamics (ANGO) Stock Sinks As Market Gains: Here's Whyfinance.yahoo.com - February 9 at 11:46 PM Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address What is the 72-Hour Profit Surge? (Ad)One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge… Click here now to get all the details. ANGO Media Mentions By Week ANGO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANGO News Sentiment▼0.000.37▲Average Medical News Sentiment ANGO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANGO Articles This Week▼13▲ANGO Articles Average Week Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Accuray News Today Surmodics News Today Cytosorbents News Today Orthofix Medical News Today Sight Sciences News Today AVITA Medical News Today Utah Medical Products News Today Pulmonx News Today Inovio Pharmaceuticals News Today Cerus News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANGO) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
